HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,005,538 | +43.4% | 78,404 | +35.0% | 0.00% | +50.0% |
Q2 2023 | $2,095,363 | -45.4% | 58,058 | -42.3% | 0.00% | -60.0% |
Q1 2023 | $3,837,705 | -19.8% | 100,564 | +19.5% | 0.01% | -16.7% |
Q4 2022 | $4,786,997 | +46.0% | 84,122 | +1.5% | 0.01% | +20.0% |
Q3 2022 | $3,279,000 | +46.8% | 82,904 | +63.2% | 0.01% | +66.7% |
Q2 2022 | $2,234,000 | -3.2% | 50,786 | -12.2% | 0.00% | 0.0% |
Q1 2022 | $2,308,000 | -9.0% | 57,838 | -8.0% | 0.00% | +50.0% |
Q4 2021 | $2,536,000 | +34.0% | 62,840 | +35.1% | 0.00% | 0.0% |
Q3 2021 | $1,892,000 | +280.7% | 46,524 | +148.4% | 0.00% | +100.0% |
Q3 2020 | $497,000 | +170.1% | 18,732 | +80.8% | 0.00% | – |
Q1 2020 | $184,000 | -21.4% | 10,362 | -20.9% | 0.00% | – |
Q4 2019 | $234,000 | -59.6% | 13,107 | -64.9% | 0.00% | -100.0% |
Q3 2019 | $579,000 | +116.9% | 37,342 | +125.0% | 0.00% | – |
Q1 2019 | $267,000 | +70.1% | 16,597 | +54.6% | 0.00% | – |
Q4 2018 | $157,000 | -15.6% | 10,738 | -42.8% | 0.00% | – |
Q4 2016 | $186,000 | +64.6% | 18,782 | +47.5% | 0.00% | -100.0% |
Q2 2012 | $113,000 | – | 12,732 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |